Platelet BioGenesis competitors

Platelet BioGenesis's competitors include Magenta Therapeutics, Cord Blood America, Synthace and International Stem Cell Corporation
Add company...
Platelet BioGenesis
Platelet BioGenesis is a biotech company which makes human platelets from stem cells.
Magenta Therapeutics
Magenta’s mission is to revolutionize stem cell transplant as the treatment for immune and blood diseases.
Cord Blood America
Cord Blood America, Inc. provides cord blood and cord tissue stem cell services.
Synthace
Synthace produces bio-based chemical products through the application of synthetic biology.
International Stem Cell Corporation
International Stem Cell Corporation is a California-based biotechnology company focused on therapeutic and research products.
Founding Date
Founding Date
2014
Founding Date
2016
Founding Date
1999
Founding Date
2011
Founding Date
2001
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Boston, US HQ
Locations
Cambridge, US HQ
Locations
Las Vegas, US HQ
Locations
London, GB HQ
Locations
Carlsbad, US HQ
Employees
Employees
23
Employees
578% increase
Employees
15
Employees
462% increase
Employees
41
Valuation ($)
Valuation ($)
N/A
Valuation ($)
418.1 m
Valuation ($)
3.7 m
Valuation ($)
N/A
Valuation ($)
6.7 m
Facebook likes
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
66
Facebook likes
3.8 k
Twitter followers
Twitter followers
248
Twitter followers
694
Twitter followers
N/A
Twitter followers
506
Twitter followers
10.1 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$3.3m (FY, 2016)
Revenue (est.)
£581 (FY, 2013)
Revenue (est.)
$7.2b (FY, 2016)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$904.9k (FY, 2016)
Cost of goods
N/A
Cost of goods
$1.9b (FY, 2016)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$2.4m (FY, 2016)
Gross profit
N/A
Gross profit
$5.2b (FY, 2016)
Net income
Net income
N/A
Net income
N/A
Net income
$102.2k (FY, 2016)
Net income
(£361.6k) (FY, 2013)
Net income
($1.1b) (FY, 2016)

Funding

Latest funding round
Latest funding round
$ 1.1m (about 1 year ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 9.9m (11 months ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 11.1m
Total funding raised
$ 150.5m
Total funding raised
N/A
Total funding raised
$ 16.2m
Total funding raised
$ 2.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Magenta Therapeutics
HQ
Cambridge, US
Employees
57↑ 8% increase

Magenta’s mission is to revolutionize stem cell transplant as the treatment for immune and blood diseases.

View company
Cord Blood America
HQ
Las Vegas, US
Employees
15

Cord Blood America, Inc. provides cord blood and cord tissue stem cell services.

View company
Synthace
HQ
London, GB
Employees
46↑ 2% increase

Synthace produces bio-based chemical products through the application of synthetic biology.

View company
International Stem Cell Corporation
HQ
Carlsbad, US
Employees
41

International Stem Cell Corporation is a California-based biotechnology company focused on therapeutic and research products.

View company